1 |
Glutamic acid
| - | 0件: | - | - | - |
2 |
Glucose
| 1件: D-glucose D-glucose | 2件: D-glucose D-glucose; Glucose; | - | - | 3件: 49 49, 86, 88 |
3 |
Glycine
| 1件: Glycine Glycine | 1件: Glycine Glycine; | - | - | 5件: 35 35, 60, 86, 226, 299 |
4 |
Glutathione
| 1件: Glutathione Glutathione | 2件: Glutathione Glutathione; Reduced Glutathione; | - | - | 2件: 6 6, 299 |
5 |
Glutamine
| 1件: L-Glutamine L-Glutamine | 2件: Glutamine Glutamine; L-Glutamine; | - | - | 7件: 87 87, 89, 96, 97, 113, 245, 299 |
6 |
Glycerin
| 1件: Glycerin Glycerin | 3件: Bee venom Bee venom; Glycerine; Glycerol; | - | - | 6件: 6 6, 13, 79, 265, 316, 317 |
7 |
gamma-Aminobutyric acid
| - | 0件: | - | - | - |
8 |
G-Strophanthin
| - | 0件: | - | - | - |
9 |
Gelatin
| 1件: Gelatin Gelatin | 3件: Gelatin Gelatin; Gelatine; Sulfur Colloid; | - | - | 7件: 19 19, 28, 62, 78, 97, 269, 299 |
10 |
Glucagon
| 1件: Glucagon Glucagon | 1件: Glucagon Glucagon; | 1件: GCGR GCGR 💬 | 2件: Glucagon signaling pathway Glucagon signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 78 78 |
11 |
Guaiacol
| - | 0件: | - | - | - |
12 |
Glycyrrhetinic acid
| - | 0件: | - | - | - |
13 |
Glycyrrhizin
| 1件: Glycyrrhizic acid Glycyrrhizic acid | 1件: Glycyrrhizin Glycyrrhizin; | - | - | 1件: 51 51 |
14 |
gamma-Amino-beta-hydroxybutyric acid
| - | 0件: | - | - | - |
15 |
Griseofulvin
| - | 0件: | - | - | - |
16 |
Gabapentin
| 1件: Gabapentin Gabapentin | 4件: Gabapentin Gabapentin; GABAPENTINA; Gabapentine; NEURONTIN; | 5件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 5件: 6 6, 13, 19, 70, 298 |
17 |
Ganciclovir
| 1件: Ganciclovir Ganciclovir | 1件: Ganciclovir Ganciclovir; | - | - | 3件: 28 28, 60, 97 |
18 |
Gemfibrozil
| - | 0件: | - | - | - |
19 |
Glipizide
| - | 0件: | - | - | - |
20 |
Glyburide
| - | 0件: | - | - | - |
21 |
Guaifenesin
| - | 0件: | - | - | - |
22 |
Glutethimide
| - | 0件: | - | - | - |
23 |
Glycopyrrolate
| - | 0件: | - | - | - |
24 |
Goserelin acetate
| 1件: Goserelin Goserelin | 1件: Goserelin Goserelin; | 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 1 1 |
25 |
Gatifloxacin
| - | 0件: | - | - | - |
26 |
Glimepiride
| - | 0件: | - | - | - |
27 |
Guanfacine hydrochloride
| 1件: Guanfacine Guanfacine | 1件: Guanfacine Guanfacine; | 1件: ADRA2A ADRA2A 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 193 193 |
28 |
Guanadrel sulfate
| - | 0件: | - | - | - |
29 |
Granisetron hydrochloride
| - | 0件: | - | - | - |
30 |
Gallium nitrate
| 1件: Gallium nitrate Gallium nitrate | 1件: Gallium nitrate Gallium nitrate; | - | - | 1件: 299 299 |
31 |
Gonadorelin hydrochloride
| 1件: Gonadorelin Gonadorelin | 2件: GnRH GnRH; Gonadorelin; | 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 76 76 |
32 |
Gold sodium thiomalate
| 1件: Sodium aurothiomalate Sodium aurothiomalate | 1件: Sodium aurothiomalate Sodium aurothiomalate; | - | - | 1件: 46 46 |
33 |
Gentian violet
| - | 0件: | - | - | - |
34 |
Gentamicin sulfate
| 1件: Gentamicin Gentamicin | 2件: Gentamicin Gentamicin; Gentamicin Sulfate; | - | - | 3件: 36 36, 113, 299 |
35 |
Glutaral
| - | 0件: | - | - | - |
36 |
Gadoteridol
| 1件: Gadoteridol Gadoteridol | 1件: Gadoteridol Gadoteridol; | - | - | 1件: 13 13 |
37 |
Gemcitabine hydrochloride
| - | 0件: | - | - | - |
38 |
Gestonorone caproate
| - | 0件: | - | - | - |
39 |
Glafenine
| - | 0件: | - | - | - |
40 |
Gefarnate
| - | 0件: | - | - | - |
41 |
Glycol salicylate
| - | 0件: | - | - | - |
42 |
Gliclazide
| - | 0件: | - | - | - |
43 |
Gadodiamide hydrate
| 1件: Gadodiamide Gadodiamide | 1件: Gadodiamide Gadodiamide; | - | - | 1件: 305 305 |
44 |
Gadoversetamide
| - | 0件: | - | - | - |
45 |
Gadopentetate dimeglumine
| 1件: Gadopentetic acid Gadopentetic acid | 1件: Gadopentetate Gadopentetate; | - | - | 2件: 13 13, 34 |
46 |
Gimeracil
| - | 0件: | - | - | - |
47 |
Glyceryl monostearate
| - | 0件: | - | - | - |
48 |
Gefitinib
| 1件: Gefitinib Gefitinib | 1件: Gefitinib Gefitinib; | 1件: EGFR EGFR 💬 | 48件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis 💬 | 1件: 75 75 |
49 |
Gemeprost
| - | 0件: | - | - | - |
50 |
Glucagon hydrochloride
| 1件: Glucagon Glucagon | 1件: Glucagon Glucagon; | 1件: GCGR GCGR 💬 | 2件: Glucagon signaling pathway Glucagon signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 78 78 |
51 |
Galantamine hydrobromide
| 1件: Galantamine Galantamine | 2件: Galantamine Galantamine; Galantamine hydrobromide; | 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 2件: 6 6, 127 |
52 |
Grepafloxacin hydrochloride
| - | 0件: | - | - | - |
53 |
Gramicidin S hydrochloride
| - | 0件: | - | - | - |
54 |
Guanethidine sulfate
| - | 0件: | - | - | - |
55 |
Gallamine triethiodide
| - | 0件: | - | - | - |
56 |
Gemcitabine
| - | 0件: | - | - | - |
57 |
Glibornuride
| - | 0件: | - | - | - |
58 |
Gliquidone
| - | 0件: | - | - | - |
59 |
Gemifloxacin mesylate
| - | 0件: | - | - | - |
60 |
Gemtuzumab ozogamicin
| - | 0件: | - | - | - |
61 |
Gonadorelin diacetate
| 1件: Gonadorelin Gonadorelin | 2件: GnRH GnRH; Gonadorelin; | 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 76 76 |
62 |
Gaboxadol
| 1件: Gaboxadol Gaboxadol | 1件: Gaboxadol Gaboxadol; | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 201 201, 206 |
63 |
Gadobenate dimeglumine
| 1件: Gadobenic acid Gadobenic acid | 2件: Gadobenate Gadobenate; MultiHance; | - | - | 3件: 13 13, 86, 88 |
64 |
Gadodiamide
| 1件: Gadodiamide Gadodiamide | 1件: Gadodiamide Gadodiamide; | - | - | 1件: 305 305 |
65 |
Gadofosveset trisodium
| - | 0件: | - | - | - |
66 |
Galactose
| 1件: Galactose Galactose | 2件: D-Galactose D-Galactose; Galactose; | - | - | 2件: 171 171, 222 |
67 |
Galantamine
| 1件: Galantamine Galantamine | 2件: Galantamine Galantamine; Galantamine hydrobromide; | 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 2件: 6 6, 127 |
68 |
Galiximab
| - | 0件: | - | - | - |
69 |
Ganaxolone
| 1件: Ganaxolone Ganaxolone | 1件: GANAXOLONE GANAXOLONE; | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 4件: 145 145, 152, 158, 206 |
70 |
Ganciclovir sodium
| 1件: Ganciclovir Ganciclovir | 1件: Ganciclovir Ganciclovir; | - | - | 3件: 28 28, 60, 97 |
71 |
Gavestinel
| - | 0件: | - | - | - |
72 |
Gestodene
| - | 0件: | - | - | - |
73 |
Gestrinone
| - | 0件: | - | - | - |
74 |
Glatiramer acetate
| 1件: Glatiramer Glatiramer | 5件: COP-1 COP-1; COPAXONE; Copolymer-1; Glatiramer; Glatiramer Acetate; | 20件: HLA-A HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 | 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 4件: 2 2, 13, 96, 156 |
75 |
Gleptoferron
| - | 0件: | - | - | - |
76 |
Gluconolactone
| - | 0件: | - | - | - |
77 |
Glucosamine
| 1件: Glucosamine Glucosamine | 1件: Glucosamine Glucosamine; | - | - | 2件: 46 46, 271 |
78 |
Glutamic acid
| - | 0件: | - | - | - |
79 |
Golimumab
| 1件: Golimumab Golimumab | 2件: GOLIMUMAB GOLIMUMAB; SIMPONI; | 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 8件: 46 46, 56, 84, 96, 97, 107, 270, 271 |
80 |
Gonadorelin acetate
| 1件: Gonadorelin Gonadorelin | 2件: GnRH GnRH; Gonadorelin; | 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 76 76 |
81 |
Glycyrrhiza
| 1件: Licorice Licorice | 2件: Licorice Licorice; Liquorice; | - | - | 2件: 53 53, 83 |
82 |
Gramicidin
| - | 0件: | - | - | - |
83 |
Granisetron
| - | 0件: | - | - | - |
84 |
Guanabenz
| 1件: Guanabenz Guanabenz | 1件: Guanabenz Guanabenz; | 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 2件: 2 2, 13 |
85 |
Guanethidine monosulfate
| - | 0件: | - | - | - |
86 |
Guanoxabenz
| - | 0件: | - | - | - |
87 |
Guar gum
| 1件: Guar gum Guar gum | 1件: Guar gum Guar gum; | - | - | 1件: 6 6 |
88 |
Goserelin
| 1件: Goserelin Goserelin | 1件: Goserelin Goserelin; | 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 1 1 |
89 |
Galsulfase
| 1件: Galsulfase Galsulfase | 2件: GALSULFASE GALSULFASE; Naglazyme; | 1件: ARSB ARSB 💬 | 3件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬 | 1件: 19 19 |
90 |
Gamithromycin
| - | 0件: | - | - | - |
91 |
Giripladib
| - | 0件: | - | - | - |
92 |
Gambir
| - | 0件: | - | - | - |
93 |
Ginger
| 1件: Ginger Ginger | 1件: Ginger Ginger; | - | - | 2件: 46 46, 271 |
94 |
Ginseng
| 1件: Ginseng Ginseng | 1件: Ginseng Ginseng; | - | - | 3件: 13 13, 46, 53 |
95 |
Green tea leaf
| 1件: Green tea leaf Green tea leaf | 4件: Green Tea Green Tea; Green Tea Extract; GREEN TEA LEAF; Tea Extract; | - | - | 5件: 6 6, 17, 28, 46, 96 |
96 |
Glisoxepide
| - | 0件: | - | - | - |
97 |
Gitoformate
| - | 0件: | - | - | - |
98 |
Gepefrine
| - | 0件: | - | - | - |
99 |
Guanazodine
| - | 0件: | - | - | - |
100 |
Gamolenic acid
| 1件: Gamolenic acid Gamolenic acid | 2件: Gamma-Linolenic acid Gamma-Linolenic acid; Linolenic acid; | - | - | 3件: 13 13, 19, 46 |
101 |
Guacetisal
| - | 0件: | - | - | - |
102 |
Gedocarnil
| - | 0件: | - | - | - |
103 |
Gadobutrol
| 1件: Gadobutrol Gadobutrol | 1件: Gadobutrol Gadobutrol; | - | - | 3件: 13 13, 22, 46 |
104 |
Gabexate
| - | 0件: | - | - | - |
105 |
Gadopentetic acid
| 1件: Gadopentetic acid Gadopentetic acid | 1件: Gadopentetate Gadopentetate; | - | - | 2件: 13 13, 34 |
106 |
Gadoteric acid
| 1件: Gadoteric acid Gadoteric acid | 3件: Dotarem Dotarem; Gadoterate; Gadoteric acid; | - | - | 2件: 13 13, 53 |
107 |
Gadoxetic acid
| - | 0件: | - | - | - |
108 |
Gallopamil
| - | 0件: | - | - | - |
109 |
Ganirelix
| - | 0件: | - | - | - |
110 |
Gatifloxacin
| - | 0件: | - | - | - |
111 |
Gemifloxacin
| - | 0件: | - | - | - |
112 |
Gentamicin
| 1件: Gentamicin Gentamicin | 2件: Gentamicin Gentamicin; Gentamicin Sulfate; | - | - | 3件: 36 36, 113, 299 |
113 |
Gadobenic acid
| 1件: Gadobenic acid Gadobenic acid | 2件: Gadobenate Gadobenate; MultiHance; | - | - | 3件: 13 13, 86, 88 |
114 |
Gonadorelin
| 1件: Gonadorelin Gonadorelin | 2件: GnRH GnRH; Gonadorelin; | 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 76 76 |
115 |
Guanadrel
| - | 0件: | - | - | - |
116 |
Guanethidine
| - | 0件: | - | - | - |
117 |
Guanfacine
| 1件: Guanfacine Guanfacine | 1件: Guanfacine Guanfacine; | 1件: ADRA2A ADRA2A 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 193 193 |
118 |
Gusperimus
| 1件: Gusperimus Gusperimus | 1件: Gusperimus Gusperimus; | - | - | 1件: 44 44 |
119 |
Golotimod
| - | 0件: | - | - | - |
120 |
German chamomile flower
| 1件: Chamomile Chamomile | 1件: MATRICARIA FLOWER MATRICARIA FLOWER; | - | - | 1件: 97 97 |
121 |
Gabapentin enacarbil
| - | 0件: | - | - | - |
122 |
Girentuximab
| - | 0件: | - | - | - |
123 |
Gisadenafil
| - | 0件: | - | - | - |
124 |
Gosogliptin
| - | 0件: | - | - | - |
125 |
Gantenerumab
| - | 0件: | - | - | - |
126 |
Ganitumab
| - | 0件: | - | - | - |
127 |
Gevokizumab
| 1件: Gevokizumab Gevokizumab | 1件: Gevokizumab Gevokizumab; | 1件: IL1B IL1B 💬 | 44件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | 4件: 41 41, 50, 56, 269 |
128 |
Glembatumumab vedotin
| - | 0件: | - | - | - |
129 |
Glucose oxidase
| - | 0件: | - | - | - |
130 |
Galeterone
| - | 0件: | - | - | - |
131 |
Ganetespib
| - | 0件: | - | - | - |
132 |
Glycerol phenylbutyrate
| 1件: Glycerol phenylbutyrate Glycerol phenylbutyrate | 3件: Glycerol Phenylbutyrate Glycerol Phenylbutyrate; GT4P; RAVICTI; | - | - | 3件: 6 6, 251, 299 |
133 |
Gemcitabine elaidate
| - | 0件: | - | - | - |
134 |
Golvatinib
| - | 0件: | - | - | - |
135 |
Glucarpidase
| - | 0件: | - | - | - |
136 |
Gandotinib
| - | 0件: | - | - | - |
137 |
Galunisertib
| - | 0件: | - | - | - |
138 |
Guselkumab
| 1件: Guselkumab Guselkumab | 2件: GUSELKUMAB GUSELKUMAB; TREMFYA; | 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 5件: 37 37, 41, 51, 96, 97 |
139 |
Gemigliptin
| - | 0件: | - | - | - |
140 |
Gedatolisib
| - | 0件: | - | - | - |
141 |
Glasdegib
| - | 0件: | - | - | - |
142 |
Grapiprant
| - | 0件: | - | - | - |
143 |
Grazoprevir
| - | 0件: | - | - | - |
144 |
Gilteritinib
| - | 0件: | - | - | - |
145 |
Glecaprevir
| - | 0件: | - | - | - |
146 |
Guadecitabine
| - | 0件: | - | - | - |
147 |
Gepotidacin
| - | 0件: | - | - | - |
148 |
Galcanezumab
| - | 0件: | - | - | - |
149 |
Glycopyrronium
| - | 0件: | - | - | - |
150 |
Gimsilumab
| - | 0件: | - | - | - |
151 |
Glesatinib
| - | 0件: | - | - | - |
152 |
Gancotamab
| - | 0件: | - | - | - |
153 |
Gosuranemab
| 1件: Gosuranemab Gosuranemab | 1件: BMS-986168 BMS-986168; | 1件: MAPT MAPT 💬 | 4件: Alzheimer disease Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 5 5 |
154 |
Glepaglutide
| - | 0件: | - | - | - |
155 |
Gefapixant
| 1件: Gefapixant Gefapixant | 1件: Gefapixant Gefapixant; | 1件: P2RX3 P2RX3 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Taste transduction 💬 | 2件: 85 85, 226 |
156 |
Gedivumab
| - | 0件: | - | - | - |
157 |
Garetosmab
| 1件: Garetosmab Garetosmab | 1件: Garetosmab Garetosmab; | - | - | 1件: 272 272 |
158 |
Gremubamab
| - | 0件: | - | - | - |
159 |
Grazoprevir
| - | 0件: | - | - | - |
160 |
Gusacitinib
| - | 0件: | - | - | - |
161 |
Genistein
| 1件: Genistein Genistein | 1件: GENISTEIN GENISTEIN; | - | - | 2件: 19 19, 299 |
162 |
Givosiran
| 1件: Givosiran Givosiran | 1件: Givosiran Givosiran; | 1件: ALAS1 ALAS1 💬 | 4件: Biosynthesis of cofactors Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬 | 1件: 254 254 |
163 |
Golodirsen
| 1件: Golodirsen Golodirsen | 2件: GOLODIRSEN GOLODIRSEN; Vyondys 53; | 1件: DMD DMD 💬 | 4件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 |
164 |
Galicaftor
| 1件: Galicaftor Galicaftor | 1件: GALICAFTOR GALICAFTOR; | 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
165 |
Glofitamab
| - | 0件: | - | - | - |
166 |
Garlic
| 1件: Garlic Garlic | 1件: Garlic Garlic; | - | - | 1件: 299 299 |